Comparison of short- and mid-term outcomes between CYPHER and TAXUS stents in patients with complex lesions of the coronary arteries

Chinese Medical Journal

Volumn 119, Issue 1, 2006, Pages 21-25

  Chen, Ji Lin ^a   Gao, Run Lin ^a   Yang, Yue Jin ^a   Qiao, Shu Bing ^a   Qin, Xue Wen ^a   Yao, Min ^a   Liu, Hai Bo ^a   Xu, Bo ^a   Wu, Yong Jian ^a   Yuan, Jin Qing ^a   Chen, Jue ^a   Dai, Jun ^a   You, Shi Jie ^a   Ma, Wei Hua ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Coronary disease; Drug eluting stent; In stent restenosis; Major adverse cardiac events

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; RAPAMYCIN;

ACUTE DISEASE; ADULT; ARTICLE; CHINA; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA ANALYSIS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DISEASE; HEART INFARCTION; HOSPITAL SERVICE; HUMAN; IMPLANTATION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; RESTENOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; COMPARATIVE STUDY; MIDDLE AGED; STENT;

CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; RETROSPECTIVE STUDIES; SIROLIMUS; STENTS;

EID: 33644974311     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200601010-00004     Document Type: Article

References (23)

1. Sousa JE, Costa MA, Abizaid A, Sousa AG, Feres F, Mattos LA, et al. Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2003;107:24-27.
2. Schofer J, Schluter M, Gershlick AH, Wijns W, Garcia E, Schampaert E, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003;362:1093-1099.
3. Schampaert E, Cohen EA, Schluter M, Reeves F, Traboulsi M, Title LM, et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 2004;43:1110-1115.
4. Holmes DR Jr, Leon MB, Moses JW, Popma JJ, Cutlip D, Fitzgerald PJ, et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimas-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation 2004; 109:634-640.
5. van Hout BA, Serruys PW, Lemos PA, van den Brand MJ, van Es GA, Lindeboom WK, et al. One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial. Heart 2005;91:507-512.
6. Fajadet J, Morice MC, Bode C, Barragan P, Serruys PW, Wijns W, et al. Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial. Circulation 2005;111: 958-960.
7. Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U, et al. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003;107:38-42.
8. Tanabe K, Serruys PW, Grube E, Smits PC, Selbach G, van der Giessen WJ, et al. TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation 2003;107:559-564.
9. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003; 108: 788-794.
10. Tanabe K, Serruys PW, Degertekin M, Guagliumi G, Grube E, Chan C, et al. Chronic arterial responses to polymer-controlled paclitaxel-eluting stent: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial. Circulation 2004; 109: 196-200.
11. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation 2004;109: 1942-1947.
12. Moses JW, Mehran R, Nikolsky E, Lasala JM, Corey W, Albin G, et al. Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial.J Am Coll Cardiol 2005;45:1165-1171.
13. Grube E, Silber S, Hauptmann KE, Buellesfeld L, Mueller R, Lim V, et al. Two-year-plus follow-up of a paclitaxel-eluting stent in de novo coronary narrowings (TAXUS I). Am J Cardiol 2005;96:79-82.
14. Hermiller JB, Raizner A, Cannon L, Gurbel PA, Kutcher MA, Wong SC, et al. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial. J Am Coll Cardiol 2005;45:1172-1179.
15. REALITY investigators. RIALITY: 8-month results of CYPHER & TAXUS comparison. ACC Annual Scientific Session 2005 Late Breaking Clinical Trial. Orlando, Florida, USA, 2005.
16. SIRTAX investigators. SIRTAX: Drug-eluting stents in patients with symptomatic coronary artery disease. ACC Annual Scientific Session 2005 Breaking Clinical Trial. Orlando, Florida, USA, 2005.
17. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364: 1519-1521.
18. Jeremias A, Sylvia B, Bridges J, Kirtane AJ, Bigelow B, Pinto DS, et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 2004;109:1930-1932.
19. Pan M, de Lezo JS, Medina A, Romero M, Segura J, Pavlovic D, et al. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy.Am Heart J 2004;148:857-864.
20. Hoye A, van Mieghem CAG, Ong ATL, Aoki J, Gaston ARG, Valgimigli M, et al. Treatment of de novo bifurcation lesions: Comparison of sirolimus- and paclitaxel-eluting stents. J Eur Intervent 2005,1: 24-30.
21. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, et al.Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 2005;293:165-171.
22. Dibra A, Kastrati A, Mehilli J, Pache J, Schuhlen H, von Beckerath N, et al. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 2005;353:663-670.
23. Windecker S, Remondino A, Eberli FR, Juni P, Raber L, Wenaweser P, et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 2005; 353: 653-662.